Votre recherche pour: Whatman+products+(Cytiva)

Ansell Guardian® - helps companies select the right PPE solution to improve safety productivity and cost performance. Webinar Tuesday 29th September 2020 11:00 to 12:00 CEST (Berlin Paris Madrid) Replay Email Alerts Free Registration Chat Area Cer...

Ansell Guardian® - helps companies select the right PPE solution to improve safety productivity and cost performance. Webinar Tuesday 29th September 2020 11:00 to 12:00 CEST (Berlin Paris Madrid) Replay Email Alerts Free Registration Chat Area Cer...

L’importance du rôle des pompes dans le développement et la production des vaccins L’être humain fait face à une multitude de menaces sanitaires de la grippe saisonnière banale aux germes pathogènes plus agressifs entraînant des maladies telles qu...

L’importance du rôle des pompes dans le développement et la production des vaccins L’être humain fait face à une multitude de menaces sanitaires de la grippe saisonnière banale aux germes pathogènes plus agressifs entraînant des maladies telles qu...

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Regulatory Agencies and Approvals ASCII: American Standard Code for Information Interchange method of encoding characters into 7 or 8 binary bits (typically 7 bits plus an 8th bit for parity). ANSI: The American National Standards Institute is a p...

Regulatory Agencies and Approvals ASCII: American Standard Code for Information Interchange method of encoding characters into 7 or 8 binary bits (typically 7 bits plus an 8th bit for parity). ANSI: The American National Standards Institute is a p...

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Continued research Moving your research forward relies on the right products and planning precisely when and where needed. Avantor is your complete resource for everything you need to ensure optimized research workflows – from consumables instrume...

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Final fill for recombinant proteins Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepar...

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Final fill for recombinant proteins Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepar...

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Solutions to manage complexity in global single-use supply chain for vaccines manufacturing Webinar On demand Replay Single-use systems have been proven to enable a more flexible cost-effective approach to manufacturing monoclonal antibodies (mAbs...